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ABSTRACT
The transcription factor HIF-1a (hypoxia inducible
factor 1a) has an essential role in the maintenance
of oxygen homeostasis in metazoans. HIF-1a
expression and activity in the hypoxic response is
regulated at the translation and post-translational
levels. However, the mechanism and modulator of
HIF-1a translation during hypoxia is not fully under-
stood. We found that HIF-1a expression during
hypoxia was upregulated by the microRNA 130
(miR-130) family. Levels of the miR-130 family are
elevated under hypoxia, and their target is DDX6
mRNA, which is a component of the P-bodies.
Furthermore, we found that a decrease of DDX6 ex-
pression by the miR-130 family enhanced the trans-
lation of HIF-1a in an internal ribosome entry site
element-dependent manner. These results reveal a
new HIF-1a translational mechanism and a role for
P-bodies in hypoxic stress.
INTRODUCTION
Metazoans respond to hypoxia with adaptive changes in
gene expression through the transcription factor HIF-1a
(hypoxia inducible factor 1a) (1–3). HIF-1a is
hydroxylated by prolyl hydroxylases (PHDs) of the
2-OG-Fe(II) dioxygenase family under normoxia, and
then hydroxylated HIF-1a is degraded by a proteasome
through interactions with the pVHL E3 ubiquitin ligase
complex (4). However, oxygen-dependent hydroxylation
of HIF is reduced in hypoxia, resulting in the stabilization,
activation (4–6), and induction of gene expression such as
glucose transporters and vascular endothelial growth
factor (VEGF). In translational regulation, it has been
suggested that activation of the PI3K-Akt-mTOR
pathway and MAPK pathway induce the translation of
HIF-1a in a 50 cap-dependent manner under normoxia
(7). Under hypoxic conditions, despite decreased global
protein translation, HIF-1a synthesis is constitutively
induced (8). Several studies have suggested that the
mRNA-binding proteins PTB and HuR interact with the
internal ribosome entry site (IRES) and facilitate the
translation of HIF-1a (9,10). Moreover, overexpressed
4E-BP and eIF4G in cancer cells also enhance the trans-
lation of HIF-1a during hypoxia (11). However, the mech-
anism and modulator of HIF-1a translation during
hypoxia have not been fully elucidated.
Recently, it was demonstrated that microRNAs
(miRNAs) are involved in the translational regulation of
mRNAs (12). miRNA genes are expressed as primary
transcripts (pri-miRNA) that are ﬁnally processed to
mature miRNAs via precursor miRNAs (pre-miRNA).
The mature miRNAs ( 22nt non-coding RNAs) form
partial base pairs, called seed matches, to target mRNAs
at the 30-untranslated region (30UTR) of the target gene.
However, plant miRNA–mRNA interactions, for
example, have an imperfect seed match (13). It has been
suggested that residues beyond the seed sequence play an
important role in central pairing (14). Finally, the mature
miRNAs guide the RNA-induced silencing complex
(RISC) to the target mRNAs (15), and these components
accumulate in the P-bodies, which are cytoplasmic foci
containing translationally repressed mRNP complexes
(16). Furthermore, it has been reported that mature
miRNAs binding to the coding sequence induce cleavage
of target mRNA in a manner similar to small interfering
RNAs (17).
On the other hand, the translation of TNF-a mRNA is
induced by the binding of the miRNA–Ago2–FXR1
complex to the TNF-a 30UTR when mammalian cells
are deprived of serum and the cell cycle is arrested (18).
Interestingly, recent studies revealed that miR-122 in liver
cells binds to the 50UTR of the hepatitis C virus (HCV)
genome and enhances HCV RNA levels (19,20). In
addition, it has been suggested that CAT-1 mRNA is
relieved from miR-122-mediated repression. The process
involves HuR for release from P-bodies, and CAT-1
mRNA reenters the polysomes (21). These studies
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negative and positive regulatory functions in targeting
mRNAs and RNA genomes (18–20,22).
In this study, we report that the miR-130 family targets
DDX6 mRNA, which is a component of the P-bodies (23),
and facilitates the translation of HIF-1a during hypoxia.
MATERIALS AND METHODS
Cell lines
The human kidney cell line HEK293 was obtained from
the Health Science Research Resources Bank (Japan) and
maintained in DMEM (Gibco) containing 10% FBS
with penicillin-streptomycin (Gibco) at 37 C with 5%
CO2. Hypoxia was achieved in a hypoxic chamber
(Wakenyaku) ﬁlled with 5% CO2 and 0.1% O2 balanced
with N2. Hippocampus neuronal cells were dissected from
18.5-day embryonic mice and dispersed by gentle pipetting
in neurobasal medium (Gibco) and centrifuged at
1000rpm for 5min. Cells were plated on poly-L-lysine
and laminin-coated dishes containing neurobasal
medium and B27 (Gibco) with penicillin–streptomycin.
Cells were cultured for 7–10 days at 37 C with 5% CO2.
Plasmid construction
Human DDX6 cDNA (clone ID: 6163439, NCBI acces-
sion BC065007) was obtained from OPEN
BIOSYSTEMS. DDX6 was ampliﬁed with primers by
PCR using DDX6 cDNA as the template. The PCR
products were cloned into the pcDNA3 vector
(Invitrogen) in the HindIII and BamHI sites. To
generate FLAG-DDX6, DDX6 ORF was cloned into
pFLAG-CMV2 (Sigma) in the NotI and BamHI sites.
The p3 FLAG-EGFP plasmid was generated by cloning
the EGFP-coding region of the pEGFP-N1 vector
(Clontech) into the p3 FLAG-myc-CMV-24 vector
(Sigma) in the BamHI and NotI sites.
For the reporter plasmid containing the DDX6 30UTR
region, DDX6 30UTR (800bp) was ampliﬁed with primers
by PCR using DDX6 cDNA as the template. The PCR
products were cloned into the psiCHECK-2 vector
(Promega) in the XhoI and NotI sites. DDX6 30UTR mu-
tagenesis was performed using the QuickChange kit
(Stratagene). For the HIF-1a 30UTR reporter plasmid,
mouse HIF-1a cDNA (RIKEN FANTOM clone
ID9330155D13, NM_010431) was obtained from
DNAFORM, Japan. The HIF-1a 30UTR (1200bp) was
ampliﬁed with primers by PCR. The PCR products were
cloned into the psiCHECK-2 vector (Promega) in the
XhoI and NotI sites.
For in vitro translation, HIF-1a IRES (259bp) in the
50UTR was ampliﬁed with primers by PCR using mouse
HIF-1a cDNA as the template. The PCR products were
cloned into the pBluescript II SK (-) vector (Stratagene) in
the XhoI and BamHI sites. A portion of the HIF-1a
coding region (437bp) was generated by SalI and
HindIII digestion of mouse HIF-1a cDNA. The fragments
were inserted into the pBluescript II SK (-) vector. The
nucleotide sequences of all constructs obtained by PCR
were conﬁrmed by DNA sequencing. The primers are
shown in Supplementary Table S3.
Western blots
HEK293 cells, 4 10
5, were seeded in 35-mm dishes. After
pre-miRNA transfection and hypoxia treatment, cells
were lysed with 200mlo f2  SDS sample buffer
(250mM Tris–HCl pH 6.8, 4% SDS, 20% glycerol,
0.01% bromophenol blue) containing 10% b-ME, har-
vested and sonicated. After boiling for 2min, proteins
were subjected to SDS-polyacrylamide gels and blotted
onto nitrocellulose membranes. Non-speciﬁc binding
sites were blocked with 5% skimed milk powder in
TBST (50mM Tris–HCl pH 7.2, 140mM NaCl, 0.05%
Tween-20) for 1h. HIF-1a antibody (1:1000), HIF-1b
antibody (1:1000), DDX6 antibody (1:5000) and Actin
antibody (1:10000) were added and incubated overnight
at 4 C. Afterward, nitrocellulose membranes were washed
three times for 10min with TBST. The membranes were
then incubated with anti-mouse or anti-rabbit secondary
antibodies conjugated with HRP (1:1000) for 1h and
washed three times for 10min with TBST. Detection was
followed by ECL (Bio-Rad) and visualized by a
VersaDOC instrument (Bio-Rad).
RNA isolation and northern blots
HEK293 cells were seeded at a density of 2 10
6 cells/
10ml in 100-mm dishes. The next day, the medium was
changed to fresh DMEM and then cells were treated with
normoxic or hypoxic conditions for 48h. RNA was ex-
tracted using Trizol (Invitrogen) according to the manu-
facturer’s protocol. The RNA was quantiﬁed by
absorbance at 260nm, and 40mg of total RNA was
resolved by electrophoresis through a 15% TBE/urea gel
(Invitrogen). After electrophoresis, the gel was stained
with ethidium bromide and transferred to Hybond N
+
(GE Healthcare) in a semi-dry transfer system (Taitech)
at 200 mA for 90min. The RNA was ﬁxed to the
membrane by a UV crosslinker and pre-hybridized in
5ml of PerfectHyb hybridization solution (Toyobo) for
60min at 37 C. One microliter of DIG labeling locked
nucleic acid probes (50mM), miR-130a LNA and
miR-130b LNA, were added to 5ml of PerfectHyb hybrid-
ization solution. Hybridization was carried out at 25 C for
24h. The membrane was washed three times for 5min at
55 C with 2 SSC/0.1% SDS, and incubated at room
temperature for 1h with anti-DIG-AP at a dilution of
1:10000 in blocking buffer (Roche). Hybridization signal
was detected using a CDP-star (Roche) and visualized by
exposure to X-ray ﬁlm. miR-130a and -130b locked nu-
cleic acids probes (Thermo) are shown in Supplementary
Table S4.
Quantitative real-time PCR
Total RNA (1mg) was reverse-transcribed at 42 C for
15min, 95 C for 2min and 4 C with random 6-mer
oligos and the ExScript RT reagent kit (Takara) in 20ml
of reaction solution. RT–PCR products were diluted 1:20.
Diluted RT–PCR products (2ml) were subjected to quan-
titative real-time PCR using a SYBR Premix Ex Taq kit
Nucleic Acids Research, 2011,Vol.39, No. 14 6087(Takara) in 20ml of reaction solution. Quantitative
real-time PCR and data analysis were performed with a
Light Cycler 1.5 system (Roche). PCR was performed as
follows: pre-denaturation at 95 C for 2min, 50–60 cycles
of denaturation at 95 C for 10sec, annealing at 55 C
for 20s and extension at 72 C for 30s. For the
reverse-transcription of pre-miRNA, the RT-enzyme
solution was added to the reaction solution after incuba-
tion at 95 C for 10s, and then reverse-transcription was
performed with random 6-mer oligos. Pri- and
pre-miRNA levels in qRT–PCR were normalized by 5S
rRNA.
For mature miRNA analysis, RT–PCR was performed
as previously described (24). Total RNA was
reverse-transcribed at 16 C for 30min, 42 C for 30min,
95 C for 2min and 4 C with 1mM of stem–loop RT
primers and the ExScript RT reagent kit (Takara).
Mature miR-130a and -130b RNA levels in qRT–PCR
were normalized by 5S rRNA based on a standard curve
using RT–PCR products from lin-4 synthetic miRNA.
Primers are shown in Supplementary Table S3.
Reporter gene assay
HEK 293 cells were seeded in 24-well plates (Iwaki) at
5 10
4 cells/well. The cells were co-transfected using
Lipofectamine LTX transfection reagent (Invitrogen)
with 170ng of ﬁreﬂy luciferase reporter plasmids and
80ng of Renilla luciferase plasmid pGL4.74 (Promega).
For the ﬁreﬂy luciferase reporter plasmid, pHRE-Luc
(T. Imai and H. Okano, unpublished data) containing
six copies of the hypoxia-response element from the trans-
ferrin promoter and pNFkB-Luc (BD Clontech) were
used. Five hours after transfection of reporter plasmids,
10nM of pre-miRNAs were transfected into the cells using
the DharmaFECT1 transfection reagent (Dharmacon). At
48h after transfection of pre-miRNAs, the cells were
exposed to 0.1% O2 or treated with 20ng/ml TNF-a for
12h. Cell extracts were prepared in Passive Lysis Buffer
(Promega) and luciferase assays were done with a
Dual-Luciferase assay kit (Promega) following the manu-
facturer’s protocol. HRE luciferase and NF-kB luciferase
values were divided by Renilla luciferase values to correct
for variations in transfection efﬁciency. Luminescence was
measured using a Centro XS3 LB 960 microplate lumines-
cence reader (Berthold).
For the HIF-1a IRES reporter assay, we used pRF
plasmid and pRhifF plasmid-containing mouse HIF-1a
IRES between Rluc and Fluc, which were a kind gift
from Dr J. Gregory Goodall (University of Adelaide,
Australia) (7). HEK293 cells were transfected with
50nM of pre-miRNAs or 50nM of siRNAs. After 48h,
cells were transfected with either pRF (250ng) or pRhifF
(250ng) for 24h. IRES activities during normoxia were
represented as the expression of ﬁreﬂy to Renilla
luciferase. For the DDX6 30UTR and HIF-1a 30UTR
reporter assay, HEK 293 cells were seeded in 24-well
plates (Iwaki) at 1 10
5 cells/well. The cells were
co-transfected using Lipofectamine 2000 transfection
reagent (Invitrogen) with 50ng of reporter plasmid and
25nM of miRNAs. After 48h, Renilla and ﬁreﬂy
luciferase were measured.
IP of RNP complexes
HEK293 cells were seeded at a density of 1 10
6 cells/
10ml in 100-mm dishes. After 48h, cells were washed
with PBS and harvested using 500ml of lysis buffer
(10mM HEPES pH 7.0, 100mM KCl, 5mM MgCl2,
0.5% NP-40, 1mM DTT) containing 100U/ml RNase
OUT (Invitrogen) and protease inhibitor cocktail
(Roche). Cell lysates were centrifuged at 15000rpm for
30min at 4 C. Supernatants were pre-incubated with
protein G sepharose (GE Healthcare) containing 0.1%
BSA at 4 C for 1h, and the resin was removed by centri-
fugation. The supernatants (600mg of protein) were
incubated with anti-DDX6 antibody at 4 C overnight. A
50% suspension of protein G sepharose containing 0.1%
BSA and including anti-DDX6 antibody was added to the
supernatants and was incubated at 4 C for 1h. The resin
was washed ﬁve times with NT2 buffer (50mM Tris–HCl
pH 7.4, 150mM NaCl, 1mM MgCl2 and 0.05% NP-40).
Additionally, the resin was incubated with 100ml NT2
buffer containing 20U of DNase I for 15min at 30 C,
then washed twice with 0.5ml NT2 buffer. For western
blots, 2 SDS sample buffer was added to the resin of
protein–RNA complexes. DDX6 protein was detected by
anti-DDX6 antibody. For RNA analysis, Trizol
(Invitrogen) was added to the resin of protein–RNA
complexes, and then RNA was isolated and dissolved in
10ml of water. The RNA (50ng) was reverse transcribed
using random 6-mer oligos and the ExScript RT reagent
kit (Takara). PCR for HIF-1a detection was performed as
follows: pre-denaturation at 94 C for 2min, 35 cycles of
denaturation at 94 C for 30s, annealing at 55 C for 30s
and extension at 72 C for 30s. PCR for GAPDH was
performed for 25 cycles. These primers are shown in
Supplementary Table S3.
For the binding assay of HIF-1a IRES or CDS RNAs
and FLAG-DDX6, RNAs were generated by linearizing
the pBluescript II SK (-) plasmid containing the mouse
HIF-1a IRES and coding region by in vitro transcription
with T7 polymerase (Roche). Three times FLAG-EGFP
or FLAG-DDX6 expressing HEK293 cells were harvested
and lysed by lysis buffer. These proteins were immunopre-
cipitated by anti-FLAG agarose beads (Sigma).
Immunoprecipitate-containing beads were mixed with
1mlo fin vitro transcripted RNA solution (0.4mg/ml) at
4 C for 1h. After washing the beads, RNA-bound
proteins were eluted by 0.5mg/ml FLAG peptide. Protein
concentration was determined by the Bio-Rad protein
assay reagent. Protein (1.4mg) was subjected to SDS–poly-
acrylamide gel electrophoresis, and 3  FLAG-EGFP or
FLAG-DDX6 expression was determined by western
blots using anti-FLAG antibody. For RT–PCR analysis,
1.4mg of protein containing RNA was incubated at 65 C
for 10min, 30 C for 5min and then the RT enzyme was
added and incubated at 42 C for 20min, 95 C for 2min
and 4 C using the ExScript RT reagent kit (Takara). PCR
was performed as follows: pre-denaturation at 94 C for
2min, 30 cycles of denaturation at 94 C for 30s and
6088 Nucleic Acids Research, 2011,Vol.39, No. 14annealing and extension at 68 C for 20s. Primers are
shown in Supplementary Table S3.
Immunocytochemistry
Cells were placed in hypoxic conditions for 48h. Cells
were ﬁxed in 4% paraformaldehyde for 30min and
permeabilized with 0.1% Triton-PBS for 3min at room
temperature. After washing three times with 3% (weight/
volume) BSA/PBST, cells were incubated with primary
antibodies overnight at 4 C. Cells were washed three
times with PBST and incubated for 1h with secondary
antibodies in 3% BSA/PBST, and then washed three
times with PBST. The nuclei of cells were counterstained
with DAPI dissolved in PBS. Finally, cells were ﬁlled with
PBST. Microscopy analyses were performed with a
Fluoview FV1000 confocal laser scanning microscope
(OLYMPUS). DDX6 was visualized with Alexa-546
conjugated goat anti-rabbit secondary antibody. MAP2
was visualized with Cy-2 conjugated anti-mouse second-
ary antibody.
In situ hybridization
Anti-sense and sense probes of pri-miR-130a (522nt) were
prepared as DIG-labeled nucleic acids. Probes of mature
miR-130a (22nt) and two mismatch mature miR-130a
were prepared as DIG-labeled locked nucleic acids
(Thermo). Parafﬁn-embedded blocks and sections of
mouse embryos (E18.5) for in situ hybridization were
obtained from Genostaff, Inc. (Japan). Hybridization
was performed with DIG-labeled miR-130a probes at con-
centrations of 100ng/ml in Probe Diluent (Genostaff) at
25 C for 24h. The sections were incubated with an
anti-DIG AP conjugate (Roche) for 2h. Coloring reac-
tions were performed overnight with NBT/BCIP
(Roche). The sections were counterstained with
Kernechtrot (Mutoh), dehydrated, and then mounted
with Malinol (Mutoh). Pri-miR-130a probes and mature
miR-130a locked nucleic acids probes are shown in
Supplementary Table S4.
For HIF-1a mRNA expression in neuronal cells,
Digoxigenin-labeled anti-sense and sense (control)
probes (Supplementary Table S4) were obtained from
Genostaff, Inc. Normoxia and hypoxia treated cells were
ﬁxed with 4% paraformaldehyde and permeabilized with
0.1% Triton-PBS for 2min at room temperature. After
washing three times with PBST, HIF-1a mRNA was
hybridized with the probe (1ng/ml) at 25 C overnight.
After washing ﬁve times with pre-warmed PBST (at
37 C), cells were incubated with anti-digoxigenin
antibody (Roche) at 25 C for 6h. Cells were washed
three times with PBST and incubated for 1h with second-
ary antibodies, and then washed three times with PBST.
The nuclei of cells were counterstained with DAPI
dissolved in PBS. Finally, cells were ﬁlled with PBST.
Microscopy analyses were performed with a Fluoview
FV1000 confocal laser scanning microscope
(OLYMPUS). DDX6 was visualized with Alexa-546
conjugated goat anti-rabbit secondary antibody. HIF-1a
mRNA was visualized with Cy-2 conjugated anti-mouse
secondary antibody.
Antibody, miRNA and siRNA
Antibodies recognizing HIF-1a (R&D systems), HIF-1b/
ARNT1 (BD Biosciences), DDX6 (BETHYL), actin
(CHEMICON), MAP2 and FLAG (Sigma) were used.
For secondary antibodies, HRP-conjugated anti-mouse
IgG (CHEMICON), peroxidase-conjugated anti-rabbit
IgG (Sigma), Alexa-546-conjugated anti-rabbit IgG
(Invitrogen) and Cy-2-conjugated anti-mouse IgG
(Jackson ImmunoResearch) were used.
miRNA precursors (pre-miR-130a, pre-miR-130b and
pre-miR negative control) were purchased from Ambion.
miRIDIAN hairpin inhibitors (miR-130a inhibitor,
miR-130b inhibitor and control) and FBXL11 siRNA
were purchased from Dharmacon. Other siRNAs were
purchased from QIAGEN. Target sequences for siRNAs
are indicated in Supplementary Table S2. Transfection of
these pre-miRNAs, miRIDIAN hairpin inhibitors and
siRNAs were performed using DharmaFECT 1 transfec-
tion reagent (Dharmacon) according to the manufacturer’s
protocol.
RESULTS
miR-130a and -130b regulate HIF-1a signaling
To investigate HIF-1a translational regulation by
miRNAs during hypoxia, we ﬁrst searched the HIF-1a
30UTR according to the miRbase database and found
that 19 potential miRNAs were predicted
(Supplementary Figure S1). Among these miRNAs, we
selected and focused on the miR-130 family, which was
recently reported to regulate angiogenesis through VEGF
expression (25). Therefore, we examined whether the
miR-130 family is involved in the HIF-1a pathway,
including VEGF regulation. We found that HEK293
cells transfected with pre-miR-130a and -130b increased
HIF-1a expression in a dose-dependent manner under
hypoxia (Figure 1A and B). However, we could not
detect HIF-1a expression in cells with pre-miR-130a and
-130b under normoxia (Figure 1A). It remains possible
that HIF-1a protein is degradated despite the presence
of the miR-130 family, since it has been reported that
HIF-1a is rapidly ubiquitinated in normoxia (4).
Furthermore, it is known that HIF-1a interacts with
HIF-1b as a heterodimeric transcription factor (26). We
found that the miR-130 family did not affect HIF-1b ex-
pression under both conditions (Supplementary Figure
S3A). In fact, HIF-1b 30UTR does not contain the
miR-130 family binding site (Supplementary Figure S2),
and HIF-1b has nucleotide sequence identities of only
23% with HIF-1a. We also observed that the endogenous
mature forms of miR-130a and -130b increased under
hypoxia in HEK293 cells (Figure 1C), and that HIF-1a
expression during hypoxia was decreased with the
addition of 200nM of miR-130a and -130b inhibitors
(Figure 1D).
Next, we examined HIF-1a activity in the presence of
pre-miR-130a and -130b. We used an HRE-luciferase
reporter gene (pHRE-Luc) which has six tandem repeats
of the HIF-1a-binding sequence from the transferrin
Nucleic Acids Research, 2011,Vol.39, No. 14 6089receptor promoter. HRE-mediated luciferase activity was
signiﬁcantly enhanced by miR-130a and -130b during
hypoxia, while a slightly increased level of luciferase was
observed in normoxia (Figure 2A). Since the luciferase
assay is more sensitive than the western blot, it may
enable the detection of some HIF-1a activity in the
absence of detectable HIF-1a protein under normoxia.
Further, we examined NFk-B signaling, since NFk-B is
the key component of VEGF-induced angiogenesis in
many tumors (27). However, pre-miR-130a and -130b
did not inﬂuence the NFk-B reporter gene (Figure 2B).
We also conﬁrmed that the levels of endogenous VEGF
mRNA in the presence of pre-miR-130a and -130b were
two times higher than that of the control under hypoxia
(Figure 2C). These results indicate that elevation of
miR-130a and -130b is involved in the regulation of
HIF-1a-induced transactivation of target genes under
hypoxia.
The miR-130 family targets DDX6
To determine whether miR-130a and -130b induce HIF-1a
expression through interactions with the HIF-1a 30UTR,
we examined luciferase expression using a Luc-HIF-1a
30UTR reporter gene. The results of the reporter assay
indicated that pre-miR-130a and -130b had slightly
increased luciferase expression (Supplementary Figure
S3B). These results suggested that miR-130b had some
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Figure 1. Effects of the miR-130 family on HIF-1a expression. (A) HEK 293 cells were transfected with 0.1–100nM of pre-miR-130a and -130b for
48h, and then cells were exposed to hypoxia for 8h. Expression levels of HIF-1a and actin were detected by western blot. Pre-miR negative control
(pre-miR N.C.) was 100nM. Left lane (control) shows untransfected cells. (B) HIF-1a expression levels under hypoxia shown in (A) were calculated
by the relative expression to actin. The ratio to the control is the mean of four independent experiments±SD. (C) Endogenous mature miR-130a
(top panel, left) and -130b (top panel, right) levels were detected by qRT–PCR. RNA levels for miR-130a and -130b were normalized by 5S rRNA.
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6090 Nucleic Acids Research, 2011,Vol.39, No. 14effect on HIF-1a induction through interactions with the
HIF-1a 30UTR. To identify the target genes of miR-130a
and -130b that strongly inﬂuence HIF-1a expression, we
focused on commonly observed genes and highly ranked
genes in four databases (Target Scan, Pictar, miRanda
and miRbase). We investigated nine genes, excepting the
MEOX2/GAX gene that has already been reported as an
miR-130a target (19) (Supplementary Table S1). As ﬁve of
nine genes resulted in inefﬁcient knock-down, we found
that among the four candidate genes (PHF, TNRC6A,
DDX6 and RSN), knock-down of the DDX6 gene
strongly enhanced HIF-1a (Supplementary Figure S4).
In fact, the expression of a luciferase reporter gene con-
taining the DDX6 30UTR was decreased by miR-130a and
-130b (Figure 3B, left), but a DDX6 30UTR mutant at the
miR-130a- and -130b-binding site (Figure 3A) showed no
change in luciferase activity (Figure 3B, right).
Furthermore, endogenous DDX6 protein levels were
down-regulated by pre-miR-130a and -130b (Figure 3C).
In contrast, overexpression of DDX6, but not
knock-down of DDX6, decreased HIF-1a expression
(Figure 3D). These results suggested that HIF-1a
expression was regulated by the miR-130 family through
DDX6.
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Figure 2. Hypoxia signaling in the miR-130 family. (A and B) Reporter assays with HRE reporter plasmid or NF-kB reporter plasmid are shown.
HEK293 cells were transfected with reporter plasmid and pre-miR-130 family members (10nM). After 48h transfection Cells were exposed to
hypoxia (A, open bars) or 20ng/ml TNF-a for 12h (B, open bars). Data are presented as means±SD (n=5, *P<0.01). Solid bars show the
luciferase activity without treatment in the pre-miR N.C. and pre-miR-130a family members (solid bars). The P-values in the left of (A) are as
follows: Control versus 130a: P=0.04; control versus 130b: P=0.02. Fireﬂy luciferase activities were analyzed and corrected for transfection
efﬁciency by the Renilla luciferase activity. (C) In the transient transfection of pre-miRNAs (0.1 and 10nM), after 48h cells were exposed to
hypoxia, and VEGF mRNA levels were analyzed by qRT–PCR. The mRNA levels were corrected for differences in b-actin mRNA. The values
during hypoxia (open bars) are represented as the ratio of control in normoxia (solid bars). Results are presented as means±SD (n=6,
**P<0.001). Pre-miR N.C. (10nM) was used as a control.
Nucleic Acids Research, 2011,Vol.39, No. 14 6091DDX6 effect on the HIF-1a IRES element
Since it has been reported that DDX6 (also known as rck/
p54), an RNA helicase, functions as an IRES translational
repressor (28), we examined whether HIF-1a IRES
activity was induced by decreasing DDX6 through
miR-130a and -130b. We used a Renilla-HIF-1a
IRES-FireFly (pRhifF) luciferase reporter gene
(Figure 4A), which has an HIF-1a IRES sequence
inserted into the dicistronic vector pRF containing the
Renilla and FireFly luciferase genes (8). We found that
transfection of pre-miR-130a and -130b had little effect
on the pRF reporter gene (Figure 4B, left), while
pre-miR-130a and -130b signiﬁcantly increased the
reporter activity in the presence of HIF-1a IRES
(Figure 4B, right). The same results were found in
DDX6 knock-down experiments (Figure 4C).
Furthermore, our results indicated that immunopre-
cipitation of endogenous DDX6 included endogenous
HIF-1a mRNAs (Figure 4D). In the binding assay of
in vitro transcribed RNA and FLAG-DDX6, we found
that DDX6 speciﬁcally bound to the HIF-1a IRES
element (259nt) in the 50UTR (Figure 4E, left), but not
to the HIF-1a coding region (Figure 4E, right). From
these results, we conclude that the increase of HIF-1a ex-
pression is attributable to the interaction between DDX6
and the HIF-1a IRES element.
Hypoxic stress suppresses DDX6 in neuronal cells
It has been shown that miR-130a expression is predomin-
ant in old mouse cerebellums, although miR-130a has
little expression in the cortex (29). We investigated the
tissue distribution of pri-miR-130a and mature
miR-130a. In situ hybridization revealed that pri-miR-
130a was expressed in the cortex, cerebellum and
kidneys in E18.5 mice (Supplementary Figure S6).
Mature miR-130a had the same pattern as pri-miR-130a,
which was expressed in the granule cells of the cortex,
cerebellum and the renal tubes of the kidneys
(Figure 5A and B). The mature form of miR-130a in
neuronal cells was increased under hypoxia; however,
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6092 Nucleic Acids Research, 2011,Vol.39, No. 14the levels of the pri and pre forms were no different
between normoxia and hypoxia (Figure 5C). Several
studies have reported that miR-130a is insensitive to
hypoxia in HUVEC, colon cancer and breast cancer cell
lines (30,31), whereas miR-130a expression is upregulated
by mitogens and proangiogenesis factors in HUVEC (25).
We found that HeLa and NIH-3T3 cell lines also showed
no increase in the mature forms of miR-130a and -130b
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not meet the signiﬁcance level (n=6; Control versus 130a: P=0.1, control versus 130b: P=0.4). (D) Endogenous DDX6 was immunoprecipitated
by anti-DDX6 antibodies or normal rabbit IgG (top panel). HIF-1a or GAPDH mRNA associated with endogenous DDX6 was analyzed by RT–
PCR of immunoprecipitates (IP sample). RT–PCR was also performed for 1mg of total RNA (control). The bottom panel shows immunoprecipitates
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(E) In vitro binding assay of the synthetic mRNA and DDX6. Anti-FLAG agarose binding 3 FLAG-EGFP or FLAG-DDX6 were mixed with
the in vitro transcribed HIF-1a IRES mRNA (259nt) and a portion of the HIF-1a-coding region mRNA (CDS, 437nt). These eluates with FLAG
peptides were detected by RT–PCR. RNA input amounts were used as the binding assay. The bottom panel shows immunoprecipitates (IP sample)
by western blots using anti-FLAG antibody.
Nucleic Acids Research, 2011,Vol.39, No. 14 6093under hypoxia (Supplementary Figure S7). Thus,
miR-130a response and processing occur in a cell
type-speciﬁc manner under hypoxic conditions.
Moreover, DDX6 was detected in discrete cytoplasmic
foci, referred to as P-bodies in neuronal cells (Figure 6A),
since DDX6 was co-localized with Dcp1a which is a
P-bodies marker (Supplementary Figure S8A). Under
hypoxia for 48h, DDX6 was reduced and the focus
number was signiﬁcantly decreased in primary cultured
neurons (Figure 6A and B). These observations were
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6094 Nucleic Acids Research, 2011,Vol.39, No. 14also made in HEK293 cells (Supplementary Figure S5).
We also found that DDX6 mRNA was at the same level
under normoxia and hypoxia (Supplementary Figure
S8B), and that 50nM of miR-130a inhibitor suppressed
the down-regulation of DDX6 under hypoxia in neurons
(Figure 6C). These results suggested that DDX6 is
down-regulated by miR-130a at the post-transcriptional
level under hypoxia. In these hypoxic conditions,
HIF-1a protein accumulated in neuronal cells, and
HIF-1a mRNA levels were not signiﬁcantly different
between normoxia and hypoxia (Figure 6D).
Thus, to determine whether HIF-1a expression was
modulated by the interaction with DDX6 in neuronal
cells, we examined the co-localization of endogenous
HIF-1a mRNA and DDX6 by ﬂuorescence in situ hybrid-
ization (Figure 7A). HIF-1a mRNA was observed in cell
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expression levels were detected by western blotting. Similar results were obtained in two independent experiments. (D) After exposure to normoxia
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normoxia (N) and hypoxia (H) for 48h.
Nucleic Acids Research, 2011,Vol.39, No. 14 6095bodies, dendrites and nuclei, although the nuclei included
non-speciﬁc binding in a reaction with the HIF-1a mRNA
sense probe. We found that HIF-1a mRNA foci
were co-localized with DDX6 foci under normoxia
(Figure 7A, top). However, there were very few HIF-1a
mRNA foci in dendrites under hypoxia, and HIF-1a
mRNA was abundant in the cell bodies. DDX6 foci
were also decreased and the co-localization of HIF-1a
mRNA and DDX6 was decreased under hypoxia
(Figure 7A, middle). Furthermore, we examined whether
HIF-1a mRNA that immunoprecipitated with endogen-
ous DDX6 was decreased under hypoxia. As shown in
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6096 Nucleic Acids Research, 2011,Vol.39, No. 14Figure 7B, HIF-1a mRNA under hypoxia was decreased
in the immunoprecipitates of DDX6 compared to those
under normoxia (Figure 7B, left, lanes 3 and 6). These
results suggest that HIF-1a mRNA does not assemble
with P-bodies under hypoxia due to a decrease of DDX6
by miR-130a.
DISCUSSION
In this study, we ﬁrst described the regulation of HIF-1a
translation during prolonged hypoxia by the miR-130
family and DDX6. As recent studies have reported that
miRNAs function both as inducers and suppressors of
translation (18), we hypothesized that HIF-1a expression
under hypoxia was enhanced by the miR-130a family and
the Ago complex thorough stimulation of the HIF-1a
30UTR. However, contrary to our hypothesis, miR-130a
and -130b regulated DDX6 to affect HIF-1a expression
rather than directly inﬂuencing HIF-1a translation under
hypoxia. It has been reported that DDX6 (rck/p54) nega-
tively regulates c-myc expression and leads to a reduction
of c-myc IRES-dependent translation (28). The IRES of
the c-myc P2 50UTR is unwound by DDX6. In addition,
recent work has shown that DDX6 broadly regulates
mRNA translation as a general translational repressor
(32). Although it is unclear whether DDX6 preferentially
interacts with the IRES element rather than general
mRNA, our studies indicated that DDX6 binds to
HIF-1a IRES elements, and a reduction of DDX6
results in an increase in HIF-1a expression. These results
may suggest that the HIF-1a IRES structure is also
unwound by DDX6, causing translational inhibition.
However, the interaction site and binding structure of
DDX6 in the c-myc IRES and the HIF-1a IRES are not
yet fully understood. We also cannot rule out the possi-
bility that the protein complex containing DDX6 affects
IRES elements, since DDX6 interacts with translational
initiation factor eIF4E, decapping enzyme Dcp1a and
P-body components.
P-bodies have dynamic structures requiring not only
mRNA decay, but also permitting the re-entry of stored
mRNAs into the translation pathway (33). In addition,
P-bodies can assemble and disassemble in response to
stress, such as amino acid starvation, oxidative stress
and endoplasmic reticulum stress (34). Knock-down of
DDX6 decreases the number of GW/P-bodies (35).
Therefore, our results suggest that when neuronal cells
are exposed to hypoxia, the DDX6-HIF-1a mRNA
complex disassembles for translational initiation of
HIF-1a. We also found that P-bodies were formed in
a reversible manner between normoxia and hypoxia
because of the increase of P-bodies in reoxygenation
(Supplementary Figure S8). Furthermore, it is known
that DDX6 is also a component of stress granules (SG).
Our results indicated that DDX6 was colocalized with the
SG marker TIAR upon arsenite-induced oxidative stress
(Supplementary Figure S9). However, TIAR foci in the
cytoplasm were not observed under normoxia, hypoxia
or reoxygenation in neuronal cells. Further investigation
is needed to determine the molecular mechanism
underlying HIF-1a translation and the induction of
P-bodies, including the DDX6 component.
We also found that the mature form of miR-130a was
increased under hypoxia. However, the levels of pri and
pre forms were not signiﬁcantly changed under normoxia
and hypoxia. Ago2 has been reported to be constitutively
expressed under hypoxia (36). Given reports showing that
knock-downs of Drosha or Ago2 accumulate the pri or
pre forms and diminish the mature forms (37,38), our data
suggest that miR-130a processing occurs in neuronal cells
under hypoxia. It is of interest whether Ago2 or other
RNAase III members have enzyme activity under
hypoxia.
In conclusion, our ﬁndings in this study support a trans-
lational mechanism of HIF-1a through miR-130 and
DDX6. First, HIF-1a mRNA levels were not inﬂuenced
by the miR-130 family under normoxic and hypoxic con-
ditions (Supplementary Figure S3C). Second, the miR-130
family suppressed DDX6 expression (Figure 3). Third, the
HIF-1a IRES element revealed an association with DDX6
(Figures 4 and 7B). Fourth, HIF-1a mRNA foci were
co-localized with P-bodies including DDX6 under
normoxia, whereas P-body and HIF-1a mRNA
assembly was reduced under hypoxia (Figure 7). Given
all the evidence, we propose a mechanism (Figure 8)
whereby HIF-1a mRNA is tethered by P-bodies in
normoxic conditions. Under hypoxia, HIF-1a mRNA is
released from the P-bodies or does not enter into P-bodies
through decreased DDX6, which is regulated by the
miR-130 family. In this way, HIF-1a translation, which
depends on IRES, is induced by preventing regulation
from translational repressor DDX6 under hypoxia. It
might also be that this mechanism facilitates HIF-1a
translation by PTB, HuR, 4E-BP1 and eIF4G as transla-
tional inducers. Our results imply that miR-130a may be
involved in the pathology of ischemic diseases such as
stroke. Further study of the translational regulation
Normoxia
Storage of HIF-1α mRNA
HIF-1α mRNA
P-bodies
AAA
DDX6
IRES
AAA DDX6
Hypoxia
Enhance of IRES 
dependent Translation
HIF-1α mRNA
Release
IRES
AAA
DDX6 mRNA
miR-130
AAA
DDX6
Figure 8. Illustration of DDX6 and HIF-1a regulation by miR-130.
HIF-1a mRNA is accompanied by DDX6 to P-bodies which restrict
translation with other P-body components under normoxia. Under
hypoxia, DDX6 protein levels are decreased by the miR-130 family,
and then HIF-1a is released from the P-bodies and facilitates
IRES-dependent translation.
Nucleic Acids Research, 2011,Vol.39, No. 14 6097caused by DDX6 and the miR-130 family will lead to new
insights into the physiology and pathogenesis of hypoxia.
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